United States · FDA National Drug Code directory

DEFEROXAMINE MESYLATE

Source ingredient · 9 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 63323-597_723278d4-d701-4b94-a615-ac07a1305e2d

Deferoxamine

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-599_723278d4-d701-4b94-a615-ac07a1305e2d

Deferoxamine

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 0409-2337_0c19b646-2901-4648-a502-a226b1eb0fef

Deferoxamine Mesylate

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Hospira, Inc.

United States · Source reference 60505-6236_9cc08e47-4f05-ff21-03b8-27f1e6ce47dc

Deferoxamine mesylate

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Apotex Corp.

United States · Source reference 60505-6237_9cc08e47-4f05-ff21-03b8-27f1e6ce47dc

Deferoxamine mesylate

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Apotex Corp.

United States · Source reference 68083-172_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629

Deferoxamine mesylate

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Gland Pharma Limited

United States · Source reference 68083-173_d14a31c5-4e8d-4e3e-b38f-d73ffddfb629

Deferoxamine mesylate

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Gland Pharma Limited

United States · Source reference 0078-0467_9f58db85-c282-46eb-94ba-594e2092ddf2

Desferal

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Novartis Pharmaceuticals Corporation

United States · Source reference 87081-467_38eff751-96c6-c48a-e063-6294a90a0e48

Desferal

INJECTION, POWDER, FOR SOLUTION / MITEM PHARMA

Browse ingredients in United States →
DEFEROXAMINE MESYLATE | Molindra Medicines